Business Context and Reporting Period
This Form 8-K is a current report filed by Inpixon (Exact name of registrant; note: metadata referenced XTI Aerospace, Inc., but the filing text identifies Inpixon) on February 4, 2019, with the earliest event reported on February 4, 2019. The company is incorporated in Nevada and is designated as an emerging growth company. The filing details amendments to existing debt agreements and the resolution of an arbitration award.
Key Financial Metrics and Obligations
- Debt Agreements: The company amended two Note Purchase Agreements with an institutional investor. The first note (dated October 12, 2018) has a principal of $2,520,000. The second note (dated December 21, 2018) has a principal of $1,895,000.
- Amendment Costs: A fee of $80,000 was added to the outstanding balance of the notes ($40,000 added to each) to cover expenses related to the Global Amendment.
- Loan Facility Increase: The maximum principal amount under a loan agreement with Sysorex, Inc. was increased from $3,000,000 to $5,000,000.
- Arbitration Liability: An arbitration award of $1,156,840.25 plus accrued interest was issued against the company. This was reduced by $275,000 to a "Net Award" of $881,840.25, to be settled via stock issuance.
- Capital Structure: As of February 8, 2019, outstanding equity includes 4,695,277 shares of common stock, 1 share of Series 4 Convertible Preferred Stock (convertible to 202 common shares), and 2,254 shares of Series 5 Convertible Preferred Stock (convertible to approximately 676,877 common shares).
Material Changes Versus Prior Period
The filing does not provide comparative financial statements (revenue, profit, or cash flow) for a prior period. Material changes reported are strictly contractual and legal:
- Debt Restructuring: Removal of the "cancellation or exchange" clause from existing note agreements and the addition of $80,000 in fees to the principal balances.
- Increased Borrowing Capacity: The Sysorex loan facility limit was raised by $2,000,000.
- Liability Settlement: Conversion of a cash arbitration liability into a stock settlement obligation, with half of the liability indemnified by Sysorex following a spin-off.
Guidance, Risks, and Contingencies
- Arbitration Contingency: The company is obligated to issue freely tradeable common stock to Atlas Technology Group, LLC, equal to 120% of the Net Award divided by the minimum price under Nasdaq Listing Rule 5635(d). This creates a dilution risk.
- Indemnification: Sysorex, Inc. is obligated to indemnify Inpixon for 50% of the total amount paid to satisfy the arbitration award.
- Liquidity and Debt: The company has increased its debt obligations through the addition of fees and the expansion of its credit line with Sysorex. The filing does not provide specific liquidity metrics or forward-looking guidance on revenue or earnings.
Investor Verification Checklist
- Verify the exact number of shares to be issued to Atlas Technology Group, LLC, as this depends on the "minimum price" calculation under Nasdaq rules.
- Confirm the total outstanding principal on the two institutional notes after the $80,000 fee addition.
- Review the full text of the Global Amendment (Exhibit 10.1) and First Amendment Agreement (Exhibit 10.2) for any additional covenants or default provisions.
- Assess the impact of the potential dilution from the Series 4 and Series 5 Convertible Preferred Stock and the new arbitration settlement shares.
- Clarify the current cash position and liquidity status, as this 8-K does not provide a balance sheet or cash flow statement.